Elucidating the exact pharmacological mechanism of action (MOA) of naturally happening compounds is usually challenging. Whilst Tarselli et al. (sixty) designed the initial de novo artificial pathway to conolidine and showcased that this naturally developing compound properly suppresses responses to each chemically induced and inflammation-derived